From Individuals to International Policy: Achievements and Ongoing Needs in Diabetes Advocacy

被引:9
作者
Hilliard, Marisa E. [1 ]
Oser, Sean M. [2 ]
Close, Kelly L. [3 ]
Liu, Nancy F. [3 ]
Hood, Korey K. [4 ]
Anderson, Barbara J. [1 ]
机构
[1] Baylor Coll Med, 1102 Bates Ave,Suite 940, Houston, TX 77030 USA
[2] Penn State Univ, Coll Med, 500 Univ Dr,HP 21, Hershey, PA 17033 USA
[3] diaTribe Fdn, 804 Haight St, San Francisco, CA 94117 USA
[4] Stanford Univ, Sch Med, 780 Welch Rd,MC 5208, Palo Alto, CA 94305 USA
关键词
Type; 1; diabetes; 2; Advocacy; Policy; HEALTH-CARE PROFESSIONALS; COMMUNITY; DISPARITIES; PROGRAMS; SOCIETY; SCIENCE; ISSUES; YOUTH;
D O I
10.1007/s11892-015-0636-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes impacts tens of millions of people in the United States of America and 9 % of the worldwide population. Given the public health implications and economic burden of diabetes, the needs of people with diabetes must be addressed through strategic and effective advocacy efforts. Diabetes advocacy aims to increase public awareness about diabetes, raise funds for research and care, influence policy impacting people with diabetes, and promote optimal individual outcomes. We present a framework for diabetes advocacy activities by individuals and at the community, national, and international levels and identify challenges and gaps in current diabetes advocacy. Various groups have organized successful diabetes advocacy campaigns toward these goals, and lessons for further advancing diabetes advocacy can be learned from other health-related populations. Finally, we discuss the role of healthcare providers and mental/ behavioral health professionals in advocacy efforts that can benefit their patients and the broader population of people with diabetes.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Antioxidants and coronary artery disease among individuals with type 1 diabetes: Findings from the Pittsburgh Epidemiology of Diabetes Complications Study
    Costacou, Tina
    Zgibor, Janice C.
    Evans, Rhobert W.
    Tyurina, Yulia Y.
    Kagan, Valerian E.
    Orchard, Trevor J.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2006, 20 (06) : 387 - 394
  • [32] Transnational Migrant Advocacy From Japan: Tipping the Scales in the Policy-making Process
    Kremers, Daniel
    PACIFIC AFFAIRS, 2014, 87 (04) : 715 - 741
  • [33] Metabolic Profile of Individuals with and without Type 2 Diabetes from Sub-Saharan Africa
    Skinner, Sarah C.
    Nemkov, Travis
    Diaw, Mor
    Mbaye, Maimouna Ndour
    Diedhiou, Demba
    Sow, Djiby
    Gueye, Fatou
    Lopez, Philomene
    Connes, Philippe
    D'Alessandro, Angelo
    JOURNAL OF PROTEOME RESEARCH, 2023, 22 (07) : 2319 - 2326
  • [34] Sexual and Reproductive Health Advocacy Successes, Failures, and Needs in the United States: Perspectives From Key Stakeholders
    Manze, Meredith
    Kwan, Amy
    Jones, Heidi
    Roberts, Lynn
    Romero, Diana
    HEALTH PROMOTION PRACTICE, 2024, 25 (02) : 183 - 187
  • [35] Biochemical analysis of microbiotas obtained from healthy, prediabetic, type 2 diabetes, and obese individuals
    Duzgun, Cagla
    Dede, Sureyya
    Karakus, Emine
    Adas, Mine
    Bilen, Omer
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2023, 48 (01): : 58 - 65
  • [36] The basal insulin dose; a lesson from prolonged fasting in young individuals with type 1 diabetes
    Strich, David
    Teomim, Renana
    Gillis, David
    PEDIATRIC DIABETES, 2015, 16 (08) : 629 - 633
  • [37] Glycaemic response to pasta from three different wheat varieties in individuals with type 2 diabetes
    Dicembrini, Ilaria
    Cavallo, Giuseppe
    Ranaldi, Francesco
    Scoccimarro, Daniele
    Caiulo, Chiara
    Silverii, Giovanni A.
    Iovino, Paolo
    Magi, Camilla E.
    Bonaccorsi, Guglielmo
    Rasero, Laura
    Mannucci, Edoardo
    DIABETES OBESITY & METABOLISM, 2025, 27 (02) : 1014 - 1017
  • [38] The Digital/Virtual Diabetes Clinic: The Future Is Now-Recommendations from an International Panel on Diabetes Digital Technologies Introduction
    Phillip, Moshe
    Bergenstal, Richard M.
    Close, Kelly L.
    Danne, Thomas
    Garg, Satish
    Heinemann, Lutz
    Hirsch, Irl B.
    Kovatchev, Boris
    Laffel, Lori M.
    Mohan, Viswanathan
    Parkin, Christopher G.
    Battelino, Tadej
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (02) : 146 - 154
  • [39] Impact of FDA Guidance for Developing Diabetes Drugs on Trial Design: From Policy to Practice
    Bethel, M. Angelyn
    Sourij, Harald
    CURRENT CARDIOLOGY REPORTS, 2012, 14 (01) : 59 - 69
  • [40] Sleep-disordered breathing and type 2 diabetes - A report from the International Diabetes Federation Taskforce on Epidemiology and Prevention
    Shaw, Jonathan E.
    Punjabi, Naresh M.
    Wilding, John P.
    Alberti, K. George M. M.
    Zimmet, Paul Z.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 81 (01) : 2 - 12